FDA approves AstraZeneca’s type-2 diabetes drug in US market
AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according
AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according
Pfizer’s investigations on gene therapy for patients with Duchenne muscular dystrophy failed to meet its primary goals, according to a company statement.
The US drug regulator has granted accelerated approval for a drug to treat chronic inflammatory liver disease to Genfit, headquartered in Nord, France,
Fifteen member states of the European Union and the European Economic Area will procure up to 40 million doses of avian influenza virus
A four-year-old child in India has been detected with avian influenza A(H9N2) in the Eastern state of West Bengal, the World Health Organization
A 59-year-old person in Mexico died in April after contracting avian influenza A(H5N2) virus, the first such death in the country, according to
The advisory committee of the US Food and Drug Administration has rejected a therapy using party drug MDMA, or ecstasy or molly to
AstraZeneca announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, for $2.4 billion.
Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or
Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer